Cervical Cancer News

HealthDay - WEDNESDAY, Nov. 14 (HealthDay News) -- A highly targeted biologic drug called cetuximab (Erbitux) is the first to extend the survival of patients with advanced colon cancer who have otherwise proved resistant to conventional chemotherapy, Canadian researchers confirmed.

Women who have had advanced precancerous lesions of the cervix are still at risk for invasive cancers up to 25 years later, Swedish researchers report.

HealthDay - WEDNESDAY, Oct. 24 (HealthDay News) -- The addition of the chemotherapy drug, docetaxel, to the standard two-drug regimen used for head and neck cancers improved the efficacy of the treatment while reducing the toxicity, two new studies report.

Reuters - An analysis of the results of several studies confirm previous reports suggesting that chemotherapy offers little or no survival benefits for young women with estrogen receptor (ER)-positive breast cancers and, if given, it should not be the sole second-phase, or "adjuvant" therapy.

A test to detect human papillomavirus (HPV) -- which causes most cervical cancers -- was far better than the standard Pap smear at catching malignancies, two new studies show.

Death rates from cancer are dropping more quickly across the United States, offering what an expert called a "glimmer of hope" against a leading killer.

Compared to conventional tests, human papillomavirus (HPV) DNA testing enables earlier detection of lesions that lead to cervical cancer, Dutch researchers say.

In the United States, preventive health exams account for about 1 in 12 adult outpatient visits to doctors, says a study that found that, each year between 2002 and 2004, about 63.5 million adults had a preventive health or gynecological check-up, at an annual cost of $7.8 billion.

The most common cause of cervical cancer is infection with the human papillomavirus. Before cancer develops in the cervix, cervical cells begin to develop abnormally -- a process known as dysplasia. These abnormal cells can be detected by a test called a Pap smear.

The most common cause of cervical cancer is infection with the human papillomavirus. Before cancer develops in the cervix, cervical cells begin to develop abnormally -- a process known as dysplasia. These abnormal cells can be detected by a test called a Pap smear.

Cervical cancer vaccines that prevent infection with the human papillomavirus (HPV) do not reduce or eliminate preexisting infections, a new study suggests.

Cervical cancer vaccines that prevent infection with the human papillomavirus (HPV) do not reduce or eliminate preexisting infections, a new study suggests.

A pap smear is used to detect changes in the cells of a woman's cervix that could indicate cancer. The test is usually recommended for all women age 21 and older, and women younger than 21 if they have been sexually active for three or more years.

A pap smear is used to detect changes in the cells of a woman's cervix that could indicate cancer. The test is usually recommended for all women age 21 and older, and women younger than 21 if they have been sexually active for three or more years.

U.S. health officials are urging parents to make sure their 11- and 12-year-old children are vaccinated against meningitis, tetanus, diphtheria, whooping cough, and cervical cancer, in a new campaign launched Wednesday.

U.S. health officials are urging parents to make sure their 11- and 12-year-old children are vaccinated against meningitis, tetanus, diphtheria, whooping cough, and cervical cancer, in a new campaign launched Wednesday.